Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Independent Panel Study Of Guidant Will Help Beyond ICDs – Panel Chair

This article was originally published in The Gray Sheet

Executive Summary

An independent panel created by Guidant will produce a case study on the company's recent handling of implantable cardioverter defibrillator safety communications by February 2006, according to panel chair Robert Myerburg, MD, University of Miami

You may also be interested in...



Guidant Focused On Trend Thresholds Instead Of Preventable Deaths – Panel

Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company

Guidant Focused On Trend Thresholds Instead Of Preventable Deaths – Panel

Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company

Physicians Implanting ICDs, Pacers Need Education On Reliability – HRS Docs

The Heart Rhythm Society should work with FDA and manufacturers to educate physicians on realistic expectations for ICD and pacemaker performance, according to participants at the Policy Conference on Pacemaker and ICD Performance

Related Content

UsernamePublicRestriction

Register

SC143429

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel